Compare GRAB & BAX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | GRAB | BAX |
|---|---|---|
| Founded | 2012 | 1931 |
| Country | Singapore | United States |
| Employees | N/A | N/A |
| Industry | Business Services | Medical/Dental Instruments |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 12.7B | 13.9B |
| IPO Year | 2021 | 1994 |
| Metric | GRAB | BAX |
|---|---|---|
| Price | $3.11 | $24.56 |
| Analyst Decision | Strong Buy | Hold |
| Analyst Count | 25 | 14 |
| Target Price | $5.76 | ★ $27.92 |
| AVG Volume (30 Days) | ★ 62.6M | 6.9M |
| Earning Date | 11-02-2026 | 10-29-2026 |
| Dividend Yield | N/A | ★ 0.16% |
| EPS Growth | ★ N/A | N/A |
| EPS | N/A | ★ 0.21 |
| Revenue | N/A | ★ $11,244,000,000.00 |
| Revenue This Year | $24.57 | $3.33 |
| Revenue Next Year | $24.75 | $2.13 |
| P/E Ratio | ★ $74.17 | $115.64 |
| Revenue Growth | N/A | ★ 5.72 |
| 52 Week Low | $2.74 | $15.73 |
| 52 Week High | $6.24 | $30.00 |
| Indicator | GRAB | BAX |
|---|---|---|
| Relative Strength Index (RSI) | 46.51 | 55.27 |
| Support Level | $2.74 | $21.28 |
| Resistance Level | $3.26 | $30.00 |
| Average True Range (ATR) | 0.11 | 0.61 |
| MACD | 0.02 | 0.17 |
| Stochastic Oscillator | 42.31 | 95.15 |
Founded in 2012, Grab provides ride-sharing services, food and grocery delivery, and financial services (payments, consumer loans, and enterprise offerings) in eight Southeast-Asian countries through its mobile platform. The company partners with merchants and riders, connecting them with consumers while charging commission to both sides. Grab has a leading market share in and derives 89% of its revenue from its core businesses, ride-sharing and food delivery. Singapore, Indonesia, and Malaysia contributed more than 70% of revenue in 2024. Grab's main competitors in Southeast Asia are Line Man and Goto. Its financial services business is still in its nascent stage and provides minimal revenue currently. The company now also generates advertising revenue.
Baxter offers a variety of medical supplies and equipment to providers. From its legacy operations, Baxter sells injectable therapies for use in care settings, including IV pumps, administrative sets, and solutions; nutritional products; and surgical sealants and hemostatic agents. Baxter expanded its portfolio of hospital-focused offerings by acquiring Hillrom in late 2021, which added basic equipment like hospital beds, operating room equipment, and patient monitoring tools to the portfolio. Baxter also sold its kidney care tools in early 2025.